| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2003 | CN1443172A Novel heteroaryl derivatives and use thereof as pharmaceuticals |
| 09/17/2003 | CN1443171A Novel heteroaryl derivatives and use thereof as pharmaceuticals |
| 09/17/2003 | CN1443170A Capsaicin receptor ligands |
| 09/17/2003 | CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis |
| 09/17/2003 | CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases |
| 09/17/2003 | CN1443166A 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3, 4-diol |
| 09/17/2003 | CN1443165A Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 09/17/2003 | CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors |
| 09/17/2003 | CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 09/17/2003 | CN1443162A New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation |
| 09/17/2003 | CN1443161A Aryl sulfonamides as serotonin antagonist for treatment of obesity |
| 09/17/2003 | CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives |
| 09/17/2003 | CN1443158A Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 09/17/2003 | CN1443155A Compounds to treat alzheimer's disease |
| 09/17/2003 | CN1443150A Noval antibiotic compounds |
| 09/17/2003 | CN1443079A Polymeric conjugates of antitumor agents |
| 09/17/2003 | CN1443078A Testosterone ester formulation for human use |
| 09/17/2003 | CN1443073A Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 09/17/2003 | CN1443072A Compositions containing ascorbic acid phosphoric acid esters |
| 09/17/2003 | CN1443071A Neuroprotective 7-beta-hydroxysteroids |
| 09/17/2003 | CN1443070A Apoptosis inhibiting composition comprising 15-keto-prostaglandin or derivative thereof |
| 09/17/2003 | CN1443069A Sustained release ranolazine formulations |
| 09/17/2003 | CN1443068A Combinations of depepotidyl peptidase IV inhibitors and other antidiabetic agents for treatment of diabete mellitus |
| 09/17/2003 | CN1443067A Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 09/17/2003 | CN1443066A Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
| 09/17/2003 | CN1443065A Pharmaceutical composition improved in peroral absorbability |
| 09/17/2003 | CN1443064A Administration of thiol-based chemoprotectant compound |
| 09/17/2003 | CN1442419A Di (N-chlorolactamic acid) potassium platinate, its preparation method and its application |
| 09/17/2003 | CN1442415A Preparation method of iso propylidene shikimic acid and its new use |
| 09/17/2003 | CN1442409A 1-per (poly) fluorophenyl-3,5-disubstituted-4,5-dihydrogen pyrazole derivative, its preparation method and application |
| 09/17/2003 | CN1442399A Method of converting inositol derivative in bitter buckwheat seed into its monomer and its extraction product |
| 09/17/2003 | CN1442201A Compound containing osteoclast formation inhibiting factor and polysaccharide |
| 09/17/2003 | CN1442199A Composition for improving intestine and gastric action |
| 09/17/2003 | CN1442150A Composite immune enhancing agent for abolone fry |
| 09/17/2003 | CN1442149A External use film forming powder for eliminating wound surface inflammation |
| 09/17/2003 | CN1442148A Daidzein drip pill and its preparation method |
| 09/17/2003 | CN1442147A Erigeron breviscapus liposome and its freeze dried powder injection fluid and preparation method |
| 09/17/2003 | CN1442146A New pharmaceutical of cactus total flavone and its preparation method |
| 09/17/2003 | CN1442145A Aspilrin slow release tablet |
| 09/17/2003 | CN1442144A Antibacterial composite medicine |
| 09/17/2003 | CN1442143A Antibacterial composite medicine |
| 09/17/2003 | CN1442142A Antibacterial composite medicine |
| 09/17/2003 | CN1442141A Ferulic acid salt injection agent |
| 09/17/2003 | CN1442140A Use of substituted morphinan and its pharmaceutically acceptable salt in preparation of medicine for treating sustaining plant state |
| 09/17/2003 | CN1442139A Medicinal composition for treating inflammation |
| 09/17/2003 | CN1442138A Fukangzuo injection fluid and its preparation method |
| 09/17/2003 | CN1442137A Crataegus leaf total flarone powder injection for treating heart and brain blood vessel disease and its preparation method |
| 09/17/2003 | CN1442136A Application of porcelain ampelopsis in preparation of medicine for preventing and treating AIDS |
| 09/17/2003 | CN1442135A Application of scutellaria root extract in preparation of anti-stomach cancer medicine |
| 09/17/2003 | CN1442134A Application of scutellaria root extract in preparation of anti esophageal cancer medicine |
| 09/17/2003 | CN1121441C Method of detecting lung disease |
| 09/17/2003 | CN1121414C Selenium compound of polysaccharide and its preparation |
| 09/17/2003 | CN1121404C Antifungal agent and its preparing process and intermediate |
| 09/17/2003 | CN1121403C Quinoxalinediones |
| 09/17/2003 | CN1121402C Crystals of piperdine derivatives, intermediates for production of same, and process for producing the same |
| 09/17/2003 | CN1121395C Compounds potentiating retinoid |
| 09/17/2003 | CN1121391C Substituted 3-cyano quinolines |
| 09/17/2003 | CN1121390C Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 09/17/2003 | CN1121389C Cyanoguanidines as cell proliferation inhibitors |
| 09/17/2003 | CN1121387C Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
| 09/17/2003 | CN1121385C Haphthyl compounds, intermediates, compositions and methods of use |
| 09/17/2003 | CN1121380C Anti tumor bis dicarboxylic diamino platinum derivatives and its medicinal composition |
| 09/17/2003 | CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
| 09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
| 09/17/2003 | CN1121374C Novel trienoic retinoid compounds and method |
| 09/17/2003 | CN1121232C Pharmaceutical composition for treatment of herpes |
| 09/17/2003 | CN1121228C Medicine for treating cardiac and cerebral vascular disease and hypertension and its preparation process |
| 09/17/2003 | CN1121224C Pharmaceutical composition comprising compound having anti Xa activity and platelet aggregation antagonist compound |
| 09/17/2003 | CN1121222C Ointment for treating sweety feet and body odor and its preparation |
| 09/17/2003 | CN1121221C Medicine preparation containing ferrous saccharin |
| 09/17/2003 | CN1121219C Novel process for manufacturing paroxetine solid dispersions |
| 09/17/2003 | CN1121218C Application of calmorex in medicine composition for treating hepatocellular carcinoma |
| 09/17/2003 | CN1121217C Immunological compound |
| 09/17/2003 | CN1121216C Veterinary use of pleuromutilin derivative |
| 09/17/2003 | CN1121215C Amino acid derivatives and active oxygen resisting agent |
| 09/17/2003 | CN1121214C Use of alicyclic diamines as immunomodulators |
| 09/17/2003 | CN1121213C Method of preparing sustained release compositions |
| 09/17/2003 | CN1121211C Detergent composition for skin |
| 09/17/2003 | CN1121200C Cosmetic composition for rejuvenation of skin without skin irratation |
| 09/16/2003 | USRE38253 Composition for contraception |
| 09/16/2003 | US6622036 Method for classifying and treating physiologic brain imbalances using quantitative EEG |
| 09/16/2003 | US6620967 Ketosis-treating agent |
| 09/16/2003 | US6620944 Process for preparing pesticidal intermediates |
| 09/16/2003 | US6620941 Process for the preparation of thiazolidinedione derivatives |
| 09/16/2003 | US6620938 Compounds that inhibit GRB2-SHC binding and process for preparing same |
| 09/16/2003 | US6620927 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering |
| 09/16/2003 | US6620919 Lipoxin compounds and their use in treating cell proliferative disorders |
| 09/16/2003 | US6620910 Of given amino acid sequence; receptor agonists; increased metabolic stability; longer duration of action; use in treatment of non-insulin-dependent type II diabetes, obesity, and type I diabetes |
| 09/16/2003 | US6620853 Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs |
| 09/16/2003 | US6620852 Surgical lubricant comprising water, propylene oxide, chlorhexidene gluconate, acetic acid, lavender, propylene glycol, methyl cellulose and/or sodium acetate; epinephrine vasoconstrictor |
| 09/16/2003 | US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen |
| 09/16/2003 | US6620850 Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors |
| 09/16/2003 | US6620847 Copolymer-1 improvements in compositions of copolymers |
| 09/16/2003 | US6620845 For therapy and prophylaxis of neurological diseases |
| 09/16/2003 | US6620844 Treating obesity and non-insulin-dependent (type II) diabetes mellitus (NIDDM) by specifically targeting the genes and gene products of cathepsins |
| 09/16/2003 | US6620843 Compound based on triptolide, 16- hydroxytriptolide or tripdiolide (2-hydroxytriptolide) which is derivatized at the 12,13-epoxy group or at the lactone ring of the parent compound. |
| 09/16/2003 | US6620842 Chalcones |
| 09/16/2003 | US6620841 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) |
| 09/16/2003 | US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 09/16/2003 | US6620835 Method of inhibiting matrix metalloproteinases |